A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

While Enhertu (trastuzumab deruxtecan, T-DXd) is an established treatment for patients with HER2-low metastatic breast cancer (mBC), there has been limited information about how well it works for ...

Patients with prior malignancy showed improved cancer-specific survival in metastatic colorectal cancer (mCRC), but prior skin tumors or malignancies diagnosed over five years earlier worsened ...

Bria-IMT combined with a checkpoint inhibitor improved overall survival in metastatic breast cancer compared to Trodelvy and chemotherapy. In triple-negative breast cancer, Bria-IMT showed a median ...

LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline TP53 Mutations Among 187 patients identified (median follow-up, 22.4 ...

Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe pain and paralysis, significantly impacting quality of life. Surgery may be ...

Adding the investigational drug elraglusib to standard first-line gemcitabine and nab-paclitaxel (GnP) may extend the lives of some patients with metastatic pancreatic ductal adenocarcinoma (PDAC), ...

Women with metastatic breast cancer often face multiple chronic conditions, and high blood pressure is among the most common.

If a person has an "aggressive" prostate cancer with a Gleason score of 9, what does that mean? What's the outlook when it comes to survival rate and prognosis. Every cancer survivor is unique, of ...